“Prospective, Case-Control Study of Serological Response After Two Doses of BNT162b2 Anti-SARS-CoV-2 MRNA Vaccine in Transfusion-Dependent Thalassemic Patients”. Mediterranean Journal of Hematology and Infectious Diseases 14, no. 1 (June 29, 2022): e2022056. Accessed June 10, 2026. https://www.mjhid.org/mjhid/article/view/4990.